Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
Andrew L. Valesano, Kalee E. Rumfelt, Derek E. Dimcheff, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009499-e1009499
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Sydney Stein, Sabrina Ramelli, Alison Grazioli, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 758-763
Open Access | Times Cited: 649
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Baisheng Li, Aiping Deng, Kuibiao Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 443
SARS-CoV-2 within-host diversity and transmission
Katrina Lythgoe, Matthew Hall, Luca Ferretti, et al.
Science (2021) Vol. 372, Iss. 6539
Open Access | Times Cited: 369
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Baisheng Li, Aiping Deng, Kuibiao Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 238
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
M. Cyrus Maher, István Bartha, Steven Weaver, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 161
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, et al.
Nature Microbiology (2022) Vol. 7, Iss. 5, pp. 640-652
Open Access | Times Cited: 158
Drivers of adaptive evolution during chronic SARS-CoV-2 infections
Sheri Harari, Maayan Tahor, Natalie Rutsinsky, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1501-1508
Open Access | Times Cited: 129
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Sarah Cobey, Daniel B. Larremore, Yonatan H. Grad, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 330-335
Open Access | Times Cited: 122
SARS-CoV-2 infection and persistence throughout the human body and brain
Daniel S. Chertow, Sydney Stein, Sabrina Ramelli, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 118
Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks
Katarina M. Braun, Gage K. Moreno, Cassia Wagner, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009849-e1009849
Open Access | Times Cited: 104
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
Ana S. González-Reiche, Hala Alshammary, Sarah Schaefer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Persistent SARS-CoV-2 infection: significance and implications
Heather Machkovech, Anne M. Hahn, Jacqueline Garonzik‐Wang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. e453-e462
Open Access | Times Cited: 52
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 48
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
Emily E. Bendall, Amy P. Callear, Amy Getz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A. Martin, et al.
Journal of Virology (2024) Vol. 98, Iss. 1
Open Access | Times Cited: 17
Intra-host evolution during SARS-CoV-2 prolonged infection
Carolina Moreira Voloch, Ronaldo da Silva Francisco, Luiz Gonzaga Paula de Almeida, et al.
Virus Evolution (2021) Vol. 7, Iss. 2
Open Access | Times Cited: 86
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Fernando Gónzález‐Candelas, Marie-Anne Shaw, Tung Gia Phan, et al.
Infection Genetics and Evolution (2021) Vol. 92, pp. 104869-104869
Open Access | Times Cited: 64
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Jing Lu, Baisheng Li, Aiping Deng, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 63
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 30
COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals
Haogao Gu, Ahmed Abdul Quadeer, Pavithra Krishnan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Leora R. Feldstein, Amadea Britton, Lauren Grant, et al.
JAMA (2024) Vol. 331, Iss. 5, pp. 408-408
Open Access | Times Cited: 13
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top